Vanguard Global Advisers’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$433K Buy
3,330
+1,338
+67% +$152K ﹤0.01% 2154
2026
Q2
$198K Hold
1,992
– – ﹤0.01% 2505
2026
Q1
$176K Buy
+1,992
New +$172K ﹤0.01% 2495

Other funds holding MLAB

Vanguard Global Advisers's MLAB Position: Q3 2026 in Review

Vanguard Global Advisers increased its Mesa Laboratories (MLAB) stake by 67% in Q3 2026, buying an estimated $152K and bringing the position to 3,330 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #2154.

Vanguard Global Advisers first reported a position in MLAB in Q1 2026 and has held it in 3 quarters since. 184 funds tracked by Wall St. Rank hold MLAB as of Q3 2026.

  • Vanguard Global Advisers held 3,330 shares of Mesa Laboratories worth $433K as of Q3 2026.
  • Vanguard Global Advisers bought 1,338 Mesa Laboratories shares in Q3 2026, an estimated $152K.
  • Mesa Laboratories made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2154 holding.
  • Vanguard Global Advisers first reported a position in Mesa Laboratories in Q1 2026 and has held it in 3 quarters since.
  • 184 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.